MRAGX | VEXPX | MRAGX / VEXPX | |
Total Expense Ratio | 1.21 | 0.44 | 275% |
Annual Report Gross Expense Ratio | 1.21 | 0.44 | 275% |
Fund Existence | 12 years | 58 years | - |
Gain YTD | -5.587 | 1.235 | -452% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 748M | 19.9B | 4% |
Annual Yield % from dividends | 0.00 | 0.40 | - |
Returns for 1 year | -3.66 | -1.90 | 193% |
Returns for 3 years | -13.12 | 5.40 | -243% |
Returns for 5 years | -15.48 | 5.07 | -305% |
Returns for 10 years | -11.47 | 19.92 | -58% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 13.86 | 0.21 | +1.54% |
abrdn Life Sciences Investors | |||
ZTWO | 50.78 | -0.01 | -0.02% |
F/M 2-Yr Invmt Grd Corp Bd ETF | |||
SEPP | 29.14 | -0.02 | -0.07% |
PGIM S&P 500 Buffer 12 ETF - Sep | |||
DEM | 46.16 | -0.10 | -0.22% |
WisdomTree Emerging Markets High Div ETF | |||
STXT | 20.16 | -0.09 | -0.44% |
Strive Total Return Bond ETF |